New interest in Berkshire? Which Chinese platform is looking to avoid US China tensions and a COVID 19 breakthrough for a drug maker

On Market View Minute, Michelle Martin discusses what was behind the surge in Berkshire Hathaway, Trip.com plans a secondary listing and Regeneron's COVID-19 breakthrough.

See omnystudio.com/listener for privacy information.